108 related articles for article (PubMed ID: 10792128)
41. Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity.
Yamamoto Y; Hakki A; Friedman H; Okubo S; Shimamura T; Hoffman PS; Rossignol J
Chemotherapy; 1999; 45(4):303-12. PubMed ID: 10394014
[TBL] [Abstract][Full Text] [Related]
42. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children.
Kalach N; Bergeret M; Benhamou PH; Dupont C; Raymond J
J Clin Microbiol; 2001 Jan; 39(1):394-7. PubMed ID: 11136811
[TBL] [Abstract][Full Text] [Related]
43. Tea enhances insulin activity.
Anderson RA; Polansky MM
J Agric Food Chem; 2002 Nov; 50(24):7182-6. PubMed ID: 12428980
[TBL] [Abstract][Full Text] [Related]
44. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori.
Park BS; Lee HK; Lee SE; Piao XL; Takeoka GR; Wong RY; Ahn YJ; Kim JH
J Ethnopharmacol; 2006 Apr; 105(1-2):255-62. PubMed ID: 16359837
[TBL] [Abstract][Full Text] [Related]
45. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
[TBL] [Abstract][Full Text] [Related]
46. High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.
Branca G; Spanu T; Cammarota G; Schito AM; Gasbarrini A; Gasbarrini GB; Fadda G
Int J Antimicrob Agents; 2004 Nov; 24(5):433-8. PubMed ID: 15519473
[TBL] [Abstract][Full Text] [Related]
47. Minimum inhibitory concentration of various single agents and the effect of their combinations against Helicobacter pylori, as estimated by a fast and simple in vitro assay method.
Bamba H; Kondo Y; Wong RM; Sekine S; Matsuzaki F
Am J Gastroenterol; 1997 Apr; 92(4):659-62. PubMed ID: 9128318
[TBL] [Abstract][Full Text] [Related]
48. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
Bai P; Zhou LY; Xiao XM; Luo Y; Ding Y
J Dig Dis; 2015 Aug; 16(8):464-70. PubMed ID: 26147515
[TBL] [Abstract][Full Text] [Related]
49. The effects of phenolic components of tea on the production of pro- and anti-inflammatory cytokines by human leukocytes in vitro.
Crouvezier S; Powell B; Keir D; Yaqoob P
Cytokine; 2001 Mar; 13(5):280-6. PubMed ID: 11243706
[TBL] [Abstract][Full Text] [Related]
50. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
Iwao E; Yamamoto K; Yokoyama Y; Hirayama F; Haga K
J Infect Chemother; 2004 Apr; 10(2):90-6. PubMed ID: 15160301
[TBL] [Abstract][Full Text] [Related]
51. Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia.
Navarro-Martínez MD; Navarro-Perán E; Cabezas-Herrera J; Ruiz-Gómez J; García-Cánovas F; Rodríguez-López JN
Antimicrob Agents Chemother; 2005 Jul; 49(7):2914-20. PubMed ID: 15980368
[TBL] [Abstract][Full Text] [Related]
52. [The resistance of Helicobacter pylori toward metronidazole and clarithromycin].
Zheng X; Hu F; Wang W
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1211-3. PubMed ID: 11769712
[No Abstract] [Full Text] [Related]
53. In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole.
Loo VG; Fallone CA; De Souza E; Lavallée J; Barkun AN
J Antimicrob Chemother; 1997 Dec; 40(6):881-3. PubMed ID: 9462442
[TBL] [Abstract][Full Text] [Related]
54. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
55. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids.
Lee WJ; Shim JY; Zhu BT
Mol Pharmacol; 2005 Oct; 68(4):1018-30. PubMed ID: 16037419
[TBL] [Abstract][Full Text] [Related]
56. Suppression of Helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils.
Matsubara S; Shibata H; Ishikawa F; Yokokura T; Takahashi M; Sugimura T; Wakabayashi K
Biochem Biophys Res Commun; 2003 Oct; 310(3):715-9. PubMed ID: 14550260
[TBL] [Abstract][Full Text] [Related]
57. [Study of Scutellaria baicalensis and Baicalin against antimicrobial susceptibility of Helicobacter pylori strains in vitro].
Wu J; Hu D; Wang KX
Zhong Yao Cai; 2008 May; 31(5):707-10. PubMed ID: 18826148
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the antigenotoxic potential of monomeric and dimeric flavanols, and black tea polyphenols against heterocyclic amine-induced DNA damage in human lymphocytes using the Comet assay.
Dhawan A; Anderson D; de Pascual-Teresa S; Santos-Buelga C; Clifford MN; Ioannides C
Mutat Res; 2002 Mar; 515(1-2):39-56. PubMed ID: 11909753
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.
van Zwet AA; de Boer WA; Schneeberger PM; Weel J; Jansz AR; Thijs JC
Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):861-4. PubMed ID: 8997557
[TBL] [Abstract][Full Text] [Related]
60. Catechin-based procyanidins from Peumus boldus Mol. aqueous extract inhibit Helicobacter pylori urease and adherence to adenocarcinoma gastric cells.
Pastene E; Parada V; Avello M; Ruiz A; García A
Phytother Res; 2014 Nov; 28(11):1637-45. PubMed ID: 24853276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
